Chronic Kidney Disease (CKD)
Also known as: Chronical Kidney Disease / CKD (Chronic Kidney Disease) / Kidney Diseases, Chronic / Kidney Disease, Chronic / Chronic Kidney Disease(CKD) / Chronic Kidney Diseases / Chronic Kidneys Disease / Chronic Kidney Disease / Chronic renal impairment (disorder) / Chronic kidney disease (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB06723 | Aluminum hydroxide | An antacid used for the symptomatic relief of heartburn, acid indigestion, and sour stomach. |
| DB06724 | Calcium carbonate | An ionic compound used as a calcium supplement or antacid used for the symptomatic relief of heartburn, acid indigestion, and sour stomach. |
| DB01012 | Cinacalcet | A calcium sensing receptor agonist used to treat secondary hyperparathyroidism in chronic kidney disease and hypercalcemia in parathyroid carcinoma. |
| DB06292 | Dapagliflozin | A sodium-glucose cotransporter 2 inhibitor used in the management of type 2 diabetes mellitus. |
| DB11682 | Daprodustat | A small-molecule hypoxia-inducible factor prolyl hydroxylase inhibitor used for the treatment of anemia in patients with chronic kidney disease. |
| DB00012 | Darbepoetin alfa | A recombinant form of human erythropoietin used to increase differentiation of progenitor cells to red blood cells in the treatment of anemia. |
| DB09038 | Empagliflozin | An SGLT2 inhibitor used to manage type 2 diabetes mellitus. |
| DB00016 | Erythropoietin | A recombinant form of human erythropoietin used to increase differentiation of progenitor cells to red blood cells in the treatment of anemia. |
| DB12865 | Etelcalcetide | A calcium sensing receptor agonist used to treat secondary hyperparathyroidism in patients with chronic kidney disease who require hemodialysis. |
| DB13995 | Ferric pyrophosphate citrate | A soluble iron compound used to maintain hemoglobin levels in patients undergoing hemodialysis. |
| DB06215 | Ferumoxytol | An intravenous iron replacement product used to treat iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD), or in patients who are unable to tolerate or who have not responded adequately to oral iron supplementation. |
| DB16165 | Finerenone | A nonsteroidal mineralocorticoid receptor antagonist indicated to lower the risk of eGFR decline, end stage kidney disease, cardiovascular death, heart attack, and hospitalization for heart failure in chronic kidney disease associated with type 2 diabetes. |
| DB01592 | Iron | An essential element commonly used for the treatment of patients with documented iron deficiency. |
| DB00331 | Metformin | A biguanide antihyperglycemic used in conjunction with diet and exercise for glycemic control in type 2 diabetes mellitus. It is also used off-label for insulin resistance in polycystic ovary syndrome (PCOS). |
| DB09107 | Methoxy polyethylene glycol-epoetin beta | A synthetic erythropoiesis stimulating agent (ESA) used to treat anemia associated with chronic kidney disease. |
| DB04847 | Roxadustat | A hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor used to treat symptomatic anemia associated with chronic kidney disease. |
| DB00052 | Somatotropin | A recombinant human growth hormone used as replacement therapy in various conditions of growth failure, growth hormone deficiency, and weakness in children and adults. |
| DB12713 | Sotagliflozin | An orally administered dual SGLT1/2 inhibitor used alongside insulin to improve glycemic control in patients with type 1 diabetes mellitus. |
| DB11761 | Tenapanor | An NHE3 inhibitor indicated for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic kidney disease, |
| DB14520 | Tetraferric tricitrate decahydrate | A phosphate binder used to control serum phosphorus levels or as an iron supplement. |
| DB12255 | Vadadustat | An oral hypoxia-inducible factor prolyl-hydroxylase inhibitor used to treat symptomatic anemia associated with chronic kidney disease in adults on chronic maintenance dialysis. |